dapoxetine has been researched along with Hypergonadotropic Hypogonadism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Althof, SE; Aversa, A; Isidori, AM; Jannini, EA; Lenzi, A | 1 |
| Bastide, C; Bruyère, F; Droupy, S; Geoffroy, R; Guy, L; Huygues, E; Karsenty, G; Marcelli, F; Rigot, JM; Robin, G | 1 |
1 review(s) available for dapoxetine and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
[Drugs for sexual medicine].
Topics: Alprostadil; Androgens; Benzylamines; Erectile Dysfunction; Female; Humans; Hypogonadism; Male; Naphthalenes; Phosphodiesterase 5 Inhibitors; Phytotherapy; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Testosterone; Urological Agents; Vasodilator Agents; Yohimbine | 2013 |
1 other study(ies) available for dapoxetine and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions.
Topics: Adult; Benzylamines; Comorbidity; Counseling; Critical Pathways; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Naphthalenes; Patient Selection; Penile Erection; Phosphodiesterase 5 Inhibitors; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Testosterone; Treatment Outcome | 2013 |